logo









Hua medicine (hkg: 02552)

Hua medicine (hkg: 02552)



Hua Medicine (HKG: 02552) is a biopharmaceutical company focused on the development and commercialization of Dorzagliatin (HMS5552), a first-in-class oral medication for the treatment of Type 2 diabetes, primarily operating in the PRC.
Sign up today to get real-time market insights on Hua medicine (hkg: 02552) and hundreds of other pre-IPO companies



Hua medicine (hkg: 02552) Overview

2011
Biotech



Hua medicine (hkg: 02552) Live Market Data

$00000000
$00000000




Hua medicine (hkg: 02552) Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
IPO9/14/2018
Series E3/26/2018
Series C4/22/2016
Series B1/8/2015
Series A10/20/2014
Early Stage VC
9/20/2011




Hua medicine (hkg: 02552) Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
ARCH Venture PartnersEarly Stage VC, Series C, Series E, Series BEarly Stage VC (2011-09-20)
F-Prime CapitalEarly Stage VC, Series C, Series EEarly Stage VC (2011-09-20)
VenrockEarly Stage VC, Series C, Series E, Series BEarly Stage VC (2011-09-20)
Eight RoadsSeries C, Series ESeries C (2016-04-22)
GIC (Singapore)Series ESeries E (2018-03-26)
Mirae Asset Global InvestmentsSeries ESeries E (2018-03-26)




Hua medicine (hkg: 02552) 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Hua medicine (hkg: 02552) data




Hua medicine (hkg: 02552) Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Hua medicine (hkg: 02552) data










DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.